146 related articles for article (PubMed ID: 24331191)
1. Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.
Carver JR; Szalda D; Ky B
Semin Oncol; 2013 Apr; 40(2):229-38. PubMed ID: 23540748
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular diseases in survivors of childhood cancer.
Bansal N; Blanco JG; Sharma UC; Pokharel S; Shisler S; Lipshultz SE
Cancer Metastasis Rev; 2020 Mar; 39(1):55-68. PubMed ID: 32026204
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology.
Muhandiramge J; Zalcberg JR; van Londen GJ; Warner ET; Carr PR; Haydon A; Orchard SG
Curr Oncol Rep; 2022 Nov; 24(11):1579-1592. PubMed ID: 35796941
[TBL] [Abstract][Full Text] [Related]
4. Caring for the adult survivor of Hodgkin lymphoma: highlighting the need for care coordination.
Tonorezos E; Overholser L
JAMA Intern Med; 2015 Jun; 175(6):1017-8. PubMed ID: 25915209
[No Abstract] [Full Text] [Related]
5. How I treat cardiovascular complications in patients with lymphoid malignancies.
Herrmann J; McCullough KB; Habermann TM
Blood; 2022 Mar; 139(10):1501-1516. PubMed ID: 34752600
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.
Chang HM; Moudgil R; Scarabelli T; Okwuosa TM; Yeh ETH
J Am Coll Cardiol; 2017 Nov; 70(20):2536-2551. PubMed ID: 29145954
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.
Bisceglia I; Canale ML; Silvestris N; Gallucci G; Camerini A; Inno A; Camilli M; Turazza FM; Russo G; Paccone A; Mistrulli R; De Luca L; Di Fusco SA; Tarantini L; Lucà F; Oliva S; Moreo A; Maurea N; Quagliariello V; Ricciardi GR; Lestuzzi C; Fiscella D; Parrini I; Racanelli V; Russo A; Incorvaia L; Calabrò F; Curigliano G; Cinieri S; Gulizia MM; Gabrielli D; Oliva F; Colivicchi F
Front Cardiovasc Med; 2023; 10():1309921. PubMed ID: 37953759
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease and lung cancer.
de Jesus M; Chanda A; Grabauskas T; Kumar M; Kim AS
Front Oncol; 2024; 14():1258991. PubMed ID: 38410099
[TBL] [Abstract][Full Text] [Related]
9. Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health-related quality of life and supportive care needs.
Maras AF; Penedo FJ; Ramirez AG; Worch SM; Ortiz MS; Yanez B; Munoz E; Lad T; Hollowell C; Medina HN; Moreno PI
Support Care Cancer; 2023 Nov; 31(12):711. PubMed ID: 37982906
[TBL] [Abstract][Full Text] [Related]
10. Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?
Mędrek S; Szmit S
Front Cardiovasc Med; 2022; 9():984951. PubMed ID: 36211566
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic Comorbidities in Cancer Survivors:
Zullig LL; Sung AD; Khouri MG; Jazowski S; Shah NP; Sitlinger A; Blalock DV; Whitney C; Kikuchi R; Bosworth HB; Crowley MJ; Goldstein KM; Klem I; Oeffinger KC; Dent S
JACC CardioOncol; 2022 Jun; 4(2):149-165. PubMed ID: 35818559
[TBL] [Abstract][Full Text] [Related]
12. Hypertension in cancer patients treated with anti-angiogenic based regimens.
Wasserstrum Y; Kornowski R; Raanani P; Leader A; Pasvolsky O; Iakobishvili Z
Cardiooncology; 2015 Dec; 1(1):6. PubMed ID: 33530150
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.
Zaborowska-Szmit M; Krzakowski M; Kowalski DM; Szmit S
J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32349387
[TBL] [Abstract][Full Text] [Related]
14. Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care.
Lee MS; Liu DW; Hung SK; Yu CC; Chi CL; Chiou WY; Chen LC; Lin RI; Huang LW; Chew CH; Hsu FC; Chan MWY; Lin HY
Front Cardiovasc Med; 2020; 7():16. PubMed ID: 32154267
[TBL] [Abstract][Full Text] [Related]
15. EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocol.
Keats MR; Grandy SA; Giacomantonio N; MacDonald D; Rajda M; Younis T
Pilot Feasibility Stud; 2016; 2():44. PubMed ID: 27965861
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer.
Ming X; Feng Y; Liu H; Zhang Y; Zhou L; Deng J
PLoS One; 2015; 10(12):e0144211. PubMed ID: 26630566
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular toxicity of multi-tyrosine kinase inhibitors in advanced solid tumors: a population-based observational study.
Srikanthan A; Ethier JL; Ocana A; Seruga B; Krzyzanowska MK; Amir E
PLoS One; 2015; 10(3):e0122735. PubMed ID: 25815472
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular prevention in the cancer survivor.
Chen CL
Curr Atheroscler Rep; 2015 Mar; 17(3):484. PubMed ID: 25637040
[TBL] [Abstract][Full Text] [Related]
19. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
